Human secretory FNDC5 protein as well as preparation method and application thereof
A FNDC5-R, secreted technology, applied in the field of genetic engineering
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] A human-derived secreted FNDC5 protein does not contain a transmembrane domain and can be directly secreted and released into the blood. The amino acid sequence of the human-derived secreted FNDC5 protein is SED ID NO: 1:
[0044] IHPGSPSAWPPRARAALRLWLGCVCFALVQADSPSAPAVNVTVRHLKANSAVVSWDVLEDEVVIGFAISQQKKDVRMLRFIQEVNTTTRSCALWGLHILPSHPGFHESYPGSSCPSLEPEWCEVTGLSLHCPFLV;
Embodiment 2
[0046] The preparation method of the human-derived secreted FNDC5 protein described in embodiment 1 comprises the following steps:
[0047]1. Design primers from different sites at the C-terminus of the FNDC5 gene, perform PCR, run electrophoresis, and detect FNDC5 subtypes that are different from the C-terminals of the three known FNDC5 isoforms reported in Pubmed (that is, new FNDC5 isoforms body), specifically:
[0048] The primers are:
[0049] Upstream primer FNDC5-F: TGAGGCCGAGAAGATGGCCTCTAA;
[0050] Downstream primer FNDC5-R: TAGTGACAATGGCTGCTCTCTGCC;
[0051] Extract RNA from Blox5 cells, reverse transcribe into cDNA, and use the above primers for PCR;
[0052] PCR reaction system:
[0053] h 2 O: 36.75 μl
[0054] Go Taq DNA Polymerase: 0.25 μl (Promega)
[0055] 5x Go Taq Buffer: 10 μl (Promega)
[0056] FNDC5-F: 1 μl
[0057] FNDC5-R: 1 μl
[0058] cDNA: 1 μl
[0059] Total: 50μl
[0060] 94°C for 5 minutes;
[0061] 94°C for 30 seconds, 56°C for 30 se...
Embodiment 3
[0154] Application of human-derived secreted FNDC5 protein in the preparation of drugs for treating obesity-related metabolic disorders
[0155] Establishment of obesity model: 6-week-old C57BL / 6 male mice were randomly divided into 3 groups, 6 mice in each group:
[0156] The first group: normal diet mice-normal saline group: negative control group, given normal diet all the time, and intraperitoneal injection of normal saline for 2 weeks after 12 weeks;
[0157] The second group: obese mice-normal saline group: as the positive control group, a high-fat diet was given to make obese mouse models, and after 12 weeks, normal saline was injected intraperitoneally for 2 weeks;
[0158] The third group: obese mice-secreted FNDC5 group: as the experimental group, high-fat diet was given to make obese mouse models, and secreted FDNC5 protein was injected intraperitoneally for 2 weeks after 12 weeks.
[0159] Administration method and administration concentration: The secreted FNDC5 ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com